ArticleJAMA network open2026
Childhood Sexual Abuse and Rates of Loneliness in Adulthood.
Article in JAMA network open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Importance: Childhood sexual abuse (CSA) is a severe early-life trauma with well-established psychiatric sequelae. Prior studies have been limited by nonrepresentative samples, broad adversity measures, and a lack of dose-response characterization or formal effect modification testing in contemporary US populations. Objectives: To examine the association between prior CSA and adult loneliness and whether this association varies by sex, race and ethnicity, and age group. Design, Setting, and Participants: This cross-sectional study used data on 53 444 adults from the 2023-2024 Behavioral Risk Factor Surveillance System, a nationally representative survey of US adults. CSA was ascertained through retrospective self-report. Exposure: Self-reported history of CSA (never, once, or more than once). Main Outcomes and Measures: The main outcome was ordinal loneliness frequency (never, rarely, sometimes, usually, or always) estimated via survey-weighted multinomial logistic regression, adjusted for age, sex, race and ethnicity, marital status, educational level, employment, language, general health status, and tobacco use. Effect modification by sex, race and ethnicity, and age was formally tested. Analyses incorporated complex survey weights and inverse probability weighting to reduce confounding by measured covariates. Results: The analytic sample comprised 53 444 US adults (mean [SD] age, 56.8 [17.7] years; 55.1% female). CSA was associated with a clear dose-response gradient. The probability of never feeling lonely decreased from 40.9% (95% CI, 40.1%-41.8%) among unexposed adults to 23.1% (95% CI, 20.0%-26.3%) after repeated exposure. The probability of always feeling lonely increased from 2.1% (95% CI, 1.8%-2.3%) to 5.3% (95% CI, 3.9%-6.6%)-a 2.5-fold increase (adjusted OR, 4.48; 95% CI, 3.05-5.91; P < .001). In a binary analysis, any CSA was associated with an absolute risk difference of 18.1 percentage points (95% CI, 15.5-20.7 percentage points; P < .001), number needed to harm of 6, and population attributable fraction of 7.5% (95% CI, 6.4%-8.5%), suggesting approximately 6.2 million US adult loneliness cases may be associated with CSA. The dose-response pattern was consistent across sex, racial and ethnic groups, and age groups. Conclusions and Relevance: In this cross-sectional study of 53 444 US adults, CSA was associated with higher adjusted probabilities of adult loneliness in a graded dose-response pattern. This finding underscores the importance of trauma-informed strategies to address long-term psychosocial vulnerability among adults who were exposed to CSA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.